Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FD772
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,195
Award facts
- Contract value 100% obligated
- $21,195.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,195.23 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and is performed at the awardee's Conshohocken, Pennsylvania facility. The contract represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio with the DLA Medical Supply Chain. The company's contract awards demonstrate capabilities across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This particular delivery order for Dupixent, a biologic immunosuppressant medication commonly used in dermatological and immunological conditions, underscores AmerisourceBergen's role in supplying specialized pharmaceuticals to military and veteran healthcare systems. The company's consistent success in competitively awarded contracts reflects its ability to meet rigorous federal procurement standards and support Defense Health Agency mission requirements.
Quick answers
Who was awarded contract SPE2DR26FD772?
SPE2DR26FD772 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FD772 worth?
The government has obligated $21,195 on SPE2DR26FD772.
Is contract SPE2DR26FD772 an order under another contract?
Yes. SPE2DR26FD772 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FD772 competed?
The extent of competition for SPE2DR26FD772 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award